Personal information

No personal information available

Activities

Collapse all

Employment (2)

Guy's Hospital: London, London, GB

2021-09 to present (Oncology )
Employment
Source: Self-asserted source
Sola Adeleke

UCL,: London , London , GB

2016-06-01 to present | Clinical Research Fellow (Metabolism & Exp Therapeutics)
Employment
Source: Self-asserted source
Sola Adeleke

Education and qualifications (3)

University College London: London, GB

2016-09 to 2021-01 | PhD
Education
Source: Self-asserted source
Sola Adeleke

University of Nottingham: Nottingham, Nottingham, GB

2010-09-20 to 2011-08-01 | MSc Oncology (Department of Molecular Medical Sciences)
Education
Source: Self-asserted source
Sola Adeleke

University of Lagos College of Medicine: Ikeja, Lagos, NG

2000-01-06 to 2008-01-28 | MBBS (medicine)
Education
Source: Self-asserted source
Sola Adeleke

Works (32)

Microsatellite Instability Testing in Colorectal Patients with Lynch Syndrome: Lessons Learned from a Case Report and How to Avoid Such Pitfalls

Personalized Medicine
2022-07 | Journal article
DOI: 10.2217/pme-2021-0128
Contributors: Sola Adeleke; Aidan Haslam; Adrian Choy; Salvador Diaz-Cano; Joao R Galante; Christos Mikropoulos; Stergios Boussios
Source: check_circle
Crossref

Application of diffusion-weighted whole-body MRI for response monitoring in multiple myeloma after chemotherapy: a systematic review and meta-analysis

European Radiology
2022-04 | Journal article
DOI: 10.1007/s00330-021-08311-z
Contributors: Kaiwen Wang; Elsa Lee; Shedrack Kenis; Simon Hallam; Athar Haroon; Simon Wan; Neil Rabin; Antonio Rojas-Garcia; Anwar Padhani; Sola Adeleke
Source: check_circle
Crossref

Reflection on Black History Month

Clinical Oncology
2022-04 | Journal article
DOI: 10.1016/j.clon.2022.03.014
Part of ISSN: 0936-6555
Source: Self-asserted source
Sola Adeleke

Metastatic Anorectal Melanoma Presenting as Seizures: An Infrequent Culprit

Diseases
2022-04-08 | Journal article
DOI: 10.3390/diseases10020021
Part of ISSN: 2079-9721
Source: Self-asserted source
Sola Adeleke

Lung SABR outcomes in patients treated in a DGH using a team-based learning approach

Lung Cancer
2022-03 | Journal article
DOI: 10.1016/s0169-5002(22)00177-5
Part of ISSN: 0169-5002
Source: Self-asserted source
Sola Adeleke

Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy

European Urology
2022-03 | Journal article
DOI: 10.1016/j.eururo.2022.02.022
Part of ISSN: 0302-2838
Source: Self-asserted source
Sola Adeleke

PSMA or Choline PET-CT Staging in Biochemical Relapse Post-prostatectomy – Are We Ready for a Change in Practice?

Clinical Oncology
2022-03 | Journal article
DOI: 10.1016/j.clon.2022.01.023
Part of ISSN: 0936-6555
Source: Self-asserted source
Sola Adeleke

Use of Novel Imaging for Patient Selection for Stereotactic Ablative Radiotherapy (SABR) in Oligometastatic Prostate Cancer (PCa): Does the PET Tracer Make a Difference?

Clinical Oncology
2022-03 | Journal article
DOI: 10.1016/j.clon.2021.11.032
Part of ISSN: 0936-6555
Source: Self-asserted source
Sola Adeleke

124 Could change in neoadjuvant chemotherapy regimen after 3 cycles lead to better outcomes in inoperable ovarian cancer?

Ovarian cancer
2021-10 | Conference poster
DOI: 10.1136/ijgc-2021-esgo.343
Source: Self-asserted source
Sola Adeleke

129 Survival outcomes of patients with T4/stage 4A cervical cancer: a 10 year real world data across 4 NHS trusts

Cervical cancer
2021-10 | Conference poster
DOI: 10.1136/ijgc-2021-esgo.10
Source: Self-asserted source
Sola Adeleke

Emerging methods for prostate cancer imaging: evaluating cancer structure and metabolic alterations more clearly

Molecular Oncology
2021-10 | Journal article
DOI: 10.1002/1878-0261.13071
Part of ISSN: 1574-7891
Part of ISSN: 1878-0261
Source: Self-asserted source
Sola Adeleke

414P Does adjuvant chemotherapy compared to surveillance improve recurrence free and overall survival in stage 3 rectal cancer patients?

Annals of Oncology
2021-09 | Journal article
DOI: 10.1016/j.annonc.2021.08.935
Part of ISSN: 0923-7534
Source: Self-asserted source
Sola Adeleke

Current Applications and Future Development of Magnetic Resonance Fingerprinting in Diagnosis, Characterization, and Response Monitoring in Cancer

Cancers
2021-09 | Journal article | Author
DOI: 10.3390/cancers13194742
Contributors: Hao Ding; Carlos Velasco Jimeno; Huihui Ye; Thomas Lindner; Matthew Grech-Sollars; James O’Callaghan; Crispin Hiley; Manil D Chouhan; Thoralf Niendorf; Dow-Mu Koh et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

PO-1462 Metastatic spinal compression referral patterns during pandemic lockdowns in Kent region UK

Radiotherapy and Oncology
2021-08 | Journal article
DOI: 10.1016/s0167-8140(21)07913-5
Part of ISSN: 0167-8140
Source: Self-asserted source
Sola Adeleke

Re: [177Lu]Lu-PSMA-617 Versus Cabazitaxel in Patients with Metastatic Castration-resistant Prostate Cancer (TheraP): A Randomised, Open-label, Phase 2 Trial

European Urology
2021-07 | Journal article
DOI: 10.1016/j.eururo.2021.04.005
Contributors: Sola Adeleke; Athar Haroon; Veeru Kasivisvanathan
Source: check_circle
Crossref

COVID-19 and its impact on the clinical specialty training recruitment process: lessons learned and the shape of future specialty recruitment in the UK

Journal of the Royal Society of Medicine
2021-06 | Journal article
DOI: 10.1177/01410768211008860
Contributors: Sola Adeleke; Chuanyu Gao
Source: check_circle
Crossref

MRI and targeted biopsies compared to transperineal mapping biopsies for targeted ablation in recurrent prostate cancer after radiotherapy: Primary outcomes of the FORECAST trial

European Urology
2021-06 | Journal article
DOI: 10.1016/s0302-2838(21)01566-9
Part of ISSN: 0302-2838
Source: Self-asserted source
Sola Adeleke

Reversing the Friday peak in metastatic cord compression referrals: Not as simple as previously thought?

Journal of Clinical Oncology
2021-05-20 | Conference poster
DOI: 10.1200/jco.2021.39.15_suppl.e14050
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Source: Self-asserted source
Sola Adeleke

394P Reversing the trend of Friday peak for metastatic spinal cord compression referrals

Annals of Oncology
2020-09 | Conference poster
DOI: 10.1016/j.annonc.2020.08.503
Part of ISSN: 0923-7534
Source: Self-asserted source
Sola Adeleke

Radiotherapy Referral Patterns for Metastatic Spinal Cord Compression

Clinical Oncology
2020-08 | Journal article
DOI: 10.1016/j.clon.2020.03.015
Part of ISSN: 0936-6555
Source: Self-asserted source
Sola Adeleke

Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole–body magnetic resonance imaging in radio-recurrent prostate cancer

BMC Medical Imaging
2019-12 | Journal article
DOI: 10.1186/s12880-019-0380-y
Part of ISSN: 1471-2342
Source: Self-asserted source
Sola Adeleke

Challenges in glucoCEST MR body imaging at 3 Tesla

Quantitative Imaging in Medicine and Surgery
2019-10 | Journal article
DOI: 10.21037/qims.2019.10.05
Part of ISSN: 2223-4292
Part of ISSN: 2223-4306
Source: Self-asserted source
Sola Adeleke

First-in-human <i>in vivo</i> non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma

BJR|case reports
2019-09 | Journal article
DOI: 10.1259/bjrcr.20190003
Part of ISSN: 2055-7159
Source: Self-asserted source
Sola Adeleke

A Phase 1 study to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activities of daily oral BAL101553, a novel tumor checkpoint controller (TCC) in adult patients with advanced solid tumors.

ASCO
2016 | Conference paper
Source: Self-asserted source
Sola Adeleke

A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC)

2016 | Conference paper
Source: Self-asserted source
Sola Adeleke

A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours

ASCO
2016 | Conference paper
Source: Self-asserted source
Sola Adeleke

Patritumab or Placebo Plus Cetuximab and Platinum-Based Therapy in Squamous Cell Carcinoma of the Head and Neck (SCCHN): a Phase 2 Study

ASCO
2016 | Conference paper
Source: Self-asserted source
Sola Adeleke

The easy book of cancer pharmacology

The easy book of cancer pharmacology
2016 | Book chapter
ISBN: 9781634850384
Source: Self-asserted source
Sola Adeleke

The use of next generation sequencing (NGS) to guide patient selection for phase 1 clinical trials

Annals of Oncology
2016-10 | Journal article
DOI: 10.1093/annonc/mdw368.44
Part of ISSN: 0923-7534
Source: Self-asserted source
Sola Adeleke

Molecular targeted agents for gastric cancer: a step forward towards personalized therapy.

2013 | Journal article
DOI: 10.3390/cancers5010064
PMID: 24216699
PMC: PMC3730303
Contributors: Cidon EU; Ellis SG; Inam Y; Adeleke S; Zarif S; Geldart T
Source: Self-asserted source
Sola Adeleke via Europe PubMed Central

Chemotherapy in elderly patients : still a challenge

Chemotherapy in elderly patients : still a challenge
Conference paper
Source: Self-asserted source
Sola Adeleke

Initial Experience of the use of New Oral Anticoagulants (NOAC) in a District General Hospital

Conference paper
Source: Self-asserted source
Sola Adeleke

Peer review (3 reviews for 1 publication/grant)

Review activity for BMC cancer (3)
How many people are using ORCID?